Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vega Stem Cell is a regenerative medicine company and clinical facility based in Tijuana, Mexico, specializing in advanced mesenchymal stem cell (MSC) therapies. The company focuses on treating a wide range of chronic and degenerative conditions, including autism, autoimmune disorders, and neurodegenerative diseases, using high-potency stem cells derived from human umbilical cord tissue. Vega Stem Cell provides personalized treatment protocols designed to reduce systemic inflammation and promote tissue repair and regeneration. As a prominent destination for medical tourism, the clinic serves an international patient base seeking innovative cellular therapies that are often unavailable or restricted in their home countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vega Stem Cell.